HLB Therapeutics Co.,Ltd. (115450.KQ)

KRW 10680.0

(-2.11%)

Long Term Debt Summary of HLB Therapeutics Co.,Ltd.

  • HLB Therapeutics Co.,Ltd.'s latest annual long term debt in 2023 was 1.84 Billion KRW , up 3733.73% from previous year.
  • HLB Therapeutics Co.,Ltd.'s latest quarterly long term debt in 2024 Q2 was 19.12 Billion KRW , up 846.02% from previous quarter.
  • HLB Therapeutics Co.,Ltd. reported annual long term debt of 48 Million KRW in 2022, down -85.03% from previous year.
  • HLB Therapeutics Co.,Ltd. reported annual long term debt of 320.7 Million KRW in 2021, up 46.64% from previous year.
  • HLB Therapeutics Co.,Ltd. reported quarterly long term debt of 2.02 Billion KRW for 2024 Q1, up 9.84% from previous quarter.
  • HLB Therapeutics Co.,Ltd. reported quarterly long term debt of 48 Million KRW for 2023 Q1, down 0.0% from previous quarter.

Annual Long Term Debt Chart of HLB Therapeutics Co.,Ltd. (2023 - 2016)

Historical Annual Long Term Debt of HLB Therapeutics Co.,Ltd. (2023 - 2016)

Year Long Term Debt Long Term Debt Growth
2023 1.84 Billion KRW 3733.73%
2022 48 Million KRW -85.03%
2021 320.7 Million KRW 46.64%
2020 218.7 Million KRW 14.85%
2019 190.42 Million KRW 0.0%
2018 - KRW 0.0%
2017 - KRW 0.0%
2016 - KRW 0.0%

Peer Long Term Debt Comparison of HLB Therapeutics Co.,Ltd.

Name Long Term Debt Long Term Debt Difference
HLB Co., Ltd. 17.93 Billion KRW 89.739%
iNtRON Biotechnology, Inc. 258.29 Million KRW -612.438%
BINEX Co., Ltd. 5.57 Billion KRW 67.012%
Bioneer Corporation 12.5 Billion KRW 85.278%
Anterogen.Co.,Ltd. - KRW -Infinity%
MEDIPOST Co., Ltd. 6.99 Billion KRW 73.692%
CrystalGenomics, Inc. 29.88 Billion USD 93.843%
Helixmith Co., Ltd 151.68 Million KRW -1113.205%
Chabiotech Co.,Ltd. 95.06 Billion KRW 98.064%
Medy-Tox Inc. 1.22 Billion KRW -50.116%
Peptron, Inc. 4.5 Billion KRW 59.107%
Amicogen, Inc. 70.65 Billion KRW 97.395%
Genexine, Inc. 22.68 Billion KRW 91.887%
LegoChem Biosciences, Inc. 528.37 Million KRW -248.275%
ALTEOGEN Inc. 1.24 Billion KRW -47.303%
PharmaResearch Co., Ltd. 970.71 Million KRW -89.57%
SillaJen, Inc. 8.13 Billion KRW 77.382%
JETEMA, Co., Ltd. 60 Billion KRW 96.933%
OliX Pharmaceuticals,Inc 35.36 Billion KRW 94.796%
Genomictree Inc. 97.51 Million KRW -1787.071%
MedPacto, Inc. 1.68 Billion KRW -9.084%
D&D Pharmatech 5.12 Billion KRW 64.063%
EASY BIO,Inc. 30 Billion KRW 93.866%
GI Innovation, Inc. 2.9 Billion KRW 36.633%